Numeric Biotech
PrivateLast Round
Seed
Apr 26, 2018
Total Funding Raised
$368,000
Company Overview
Numeric Biotech is a biotechnology company that develops senolytic therapies to treat and prevent age-related diseases and chronic inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Numeric Biotech Comparables
Compare Numeric Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cleara Biotech | 87% | |
| Rubedo Life Sciences | 79% | |
| Centenara Labs AG | 79% | |
Numeric Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 26, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2018
$368K raised from uniiq and Erasmus MC.
Numeric Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Numeric Biotech's valuation, stock price, and market status.